If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksABAL.L Regulatory News (ABAL)

  • There is currently no data for ABAL

Update on potential equity investment

4 Sep 2018 07:00

RNS Number : 6390Z
Imaginatik PLC
04 September 2018
 

 

Imaginatik PLC

("Imaginatik" or the "Company")

Update on potential equity investment and notification of annual audited results

 

Imaginatik plc (AIM: IMTK.L), the #1 ranked leader in corporate innovation management according to Forrester Research, provides a further update following the announcement made on 17 August 2018.

 

The Company confirms that the investor continues to be in discussions to make a controlling equity investment in the Company, likely to be at a price of 2.5 pence per ordinary share (the "Equity Investment").

 

In relation to the Equity Investment, the Company is currently seeking confirmations from certain independent shareholders of the Company, in order to obtain, on behalf of the investor, a dispensation in accordance with Note 5(c) in the Notes on Dispensations from Rule 9 of the City Code on Takeovers and Mergers (the "Code") from the obligation for the investor to make a mandatory offer under Rule 9 of the Code.

 

The Company also confirms that it is in the process of finalising its audited financial statements for the year ended 31 March 2018.

 

The Company expects to provide a full update to shareholders on all of these matters during the first half of September.

 

This announcement contains inside information for the purposes of article 7 of Regulation 596/2014.

 

 

For further information please contact:

 

Imaginatik PLC

Tel: 01329 243 243

Shawn Taylor, CFO

 

finnCap Ltd - Nomad and broker

 

Tel: 020 7220 0500

Jonny Franklin-Adams/Max Bullen-Smith, corporate finance

Camille Gochez, ECM

 

Peterhouse Capital Limited - Joint broker

 

Tel: 020 7220 9797

Duncan Vasey / Lucy Williams

 

Alma PR

 

Tel: 020 8004 4218

Caroline Forde / Robyn Fisher

About Imaginatik

 

Imaginatik is the only innovation solution provider which has combined a proven innovation program with purpose-built idea management software to enable companies to achieve breakthrough and continuous innovation at scale. Imaginatik works with leading global enterprises to build and integrate innovation management skills as a core competency. Customers include ExxonMobil, Altria, Shell, Goodyear, AECOM, Caterpillar, Novartis and Cargill.

 

Imaginatik is a public company traded on the AIM market of the London Stock Exchange (LSE: IMTK.L) with offices in Boston, MA, USA and Fareham, U.K.

 

For more information visit www.imaginatik.com 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
UPDUOUBRWBAKRAR
Date   Source Headline
27th Nov 20137:00 amRNSHalf Yearly Report
24th Oct 20137:00 amRNSContract Win
10th Oct 201310:01 amRNSHolding(s) in Company
2nd Oct 20137:00 amRNSIssue of Equity
1st Oct 201310:03 amRNSTransaction in Own Shares/Director's Dealing
23rd Sep 20137:00 amRNSContract Win with Shell
18th Sep 20132:03 pmRNSResult of AGM
27th Aug 20131:50 pmRNSNotice of AGM
24th Jul 20137:00 amRNSFinal Results
8th Jul 20137:00 amRNSContract Win
1st Jul 20137:00 amRNSChange of Adviser
21st Jun 20137:00 amRNSBoard Changes
13th Jun 20137:00 amRNSConsultancy Update
31st May 20137:00 amRNSTotal Voting Rights
16th May 20131:03 pmRNSHolding(s) in Company
16th May 20137:00 amRNSHolding(s) in Company
13th May 201312:16 pmRNSResult of General Meeting
26th Apr 20134:52 pmRNSPublication of Circular
26th Apr 20137:00 amRNSProposed Placing
16th Apr 201312:20 pmRNSCapital Market Strategy Update
7th Feb 20132:25 pmRNSTrading Update
10th Dec 20127:00 amRNSContract Wins
22nd Nov 20127:00 amRNSShare Options
21st Nov 20127:00 amRNSHalf Yearly Report
25th Oct 20127:00 amRNSTrading Update
2nd Oct 20127:00 amRNSLitigation Conclusion
14th Sep 20121:02 pmRNSResult of AGM
14th Sep 20127:00 amRNSAGM Statement
23rd Aug 20127:00 amRNSNotice of AGM
4th Jul 201212:04 pmRNSHolding(s) in Company
2nd Jul 20122:22 pmRNSHolding(s) in Company
29th Jun 20123:30 pmRNSHolding(s) in Company
29th Jun 201212:12 pmRNSHolding(s) in Company
28th Jun 20121:36 pmRNSHolding(s) in Company
27th Jun 201211:20 amRNSResult of General Meeting
20th Jun 20121:41 pmRNSDirectorate Change
11th Jun 20128:30 amRNSDirector/PDMR Shareholding
11th Jun 20128:00 amRNSProposed Placing
11th Jun 20128:00 amRNSFinal Results
17th Apr 20127:00 amRNSTrading Update
17th Apr 20127:00 amRNSContract Wins
29th Feb 20127:00 amRNSContract with US Healthcare Services Provider
21st Feb 20121:45 pmRNSHolding(s) in Company
20th Feb 201212:54 pmRNSHolding(s) in Company
15th Feb 201212:16 pmRNSHolding(s) in Company
15th Feb 20127:00 amRNSShare Option Schemes
8th Feb 20127:00 amRNSIssue of Equity
3rd Feb 201211:39 amRNSHolding(s) in Company
2nd Feb 201210:49 amRNSHolding(s) in Company
30th Jan 20127:00 amRNSSenior Management Appointments

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.